Cerity Partners
MEDP icon

Cerity Partners’s Medpace MEDP Stock Holding History

Cerity Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28M Sell
52,906
-29,171
-36% -$13.5M 0.03% 381
2026
Q1 		$39.4M Buy
82,077
+1,104
+1% +$565K 0.06% 288
2025
Q4 		$45.5M Buy
80,973
+23,530
+41% +$13.4M 0.07% 253
2025
Q3 		$29.5M Buy
57,443
+21,726
+61% +$9.49M 0.05% 303
2025
Q2 		$11.2M Sell
35,717
-7,267
-17% -$2.18M 0.02% 496
2025
Q1 		$13.1M Sell
42,984
-3,695
-8% -$1.24M 0.03% 427
2024
Q4 		$15.5M Sell
46,679
-15,211
-25% -$5.16M 0.03% 376
2024
Q3 		$20.7M Buy
61,890
+9,741
+19% +$3.7M 0.05% 311
2024
Q2 		$21.5M Buy
52,149
+11,689
+29% +$4.63M 0.06% 266
2024
Q1 		$16.4M Buy
40,460
+37,997
+1,543% +$13.4M 0.04% 340
2023
Q4 		$755K Buy
2,463
+189
+8% +$51K ﹤0.01% 1097
2023
Q3 		$551K Buy
+2,274
New +$582K ﹤0.01% 947
2023
Q2 		– Sell
-1,944
Closed -$366K – 1836
2023
Q1 		$366K Sell
1,944
-227
-10% -$46.9K ﹤0.01% 1440
2022
Q4 		$461K Buy
+2,171
New +$434K ﹤0.01% 973

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cerity Partners's MEDP Position: Q2 2026 in Review

Cerity Partners reduced its Medpace (MEDP) stake by 36% in Q2 2026, selling an estimated $13.5M and leaving 52,906 shares worth $28M. The position accounts for 0.03% of the portfolio, ranked #381.

Cerity Partners first reported a position in MEDP in Q4 2022 and has held it in 14 quarters since. The position peaked at $45.5M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Cerity Partners held 52,906 shares of Medpace worth $28M as of Q2 2026.
  • Cerity Partners sold 29,171 Medpace shares in Q2 2026, an estimated $13.5M.
  • Medpace made up 0.03% of Cerity Partners's portfolio in Q2 2026, its #381 holding.
  • Cerity Partners first reported a position in Medpace in Q4 2022 and has held it in 14 quarters since.
  • Cerity Partners's Medpace position peaked at $45.5M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.